References - Homocysteine in Protein Structure/Function and Human Disease - page 153

436. Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW. Homocysteine
binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler
Thromb Vasc Biol. 2002;22(8):1354-9.
437. Hubmacher D, Sabatier L, Annis DS, Mosher DF, Reinhardt DP. Homocysteine modifies
structural and functional properties of fibronectin and interferes with the fibronectin-fibrillin-
1 interaction. Biochemistry. 2011;50(23):5322-32.
438. Cirulis JT, Bellingham CM, Davis EC, Hubmacher D, Reinhardt DP, Mecham RP, et al.
Fibrillins, fibulins, and matrix-associated glycoprotein modulate the kinetics and morphology
of in vitro self-assembly of a recombinant elastin-like polypeptide. Biochemistry. 2008;47
(47):12601-13.
439. Brown PL, Mecham L, Tisdale C, Mecham RP. The cysteine residues in the carboxy terminal
domain of tropoelastin form an intrachain disulfide bond that stabilizes a loop structure and
positively charged pocket. Biochem Biophys Res Commun. 1992;186(1):549-55.
440. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, et al. Complete cDNA
and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA. 1987;84
(14):4846-50.
441. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and
human factor Va by activated protein C. J Biol Chem. 1994;269(50):31869-80.
442. Undas A, Williams EB, Butenas S, Orfeo T, Mann KG. Homocysteine inhibits inactivation of
factor Va by activated protein C. J Biol Chem. 2001;276(6):4389-97.
443. Lentz SR, Piegors DJ, Fernandez JA, Erger RA, Arning E, Malinow MR, et al. Effect of
hyperhomocysteinemia on protein C activation and activity. Blood. 2002;100(6):2108-12.
444. Flood EC, Hajjar KA. The annexin A2 system and vascular homeostasis. Vascul Pharmacol.
2011;54(3-6):59-67.
445. Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its
endothelial cell membrane receptor. J Clin Invest. 1993;91(6):2873-9.
446. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, et al. Tissue plasmino-
gen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J
Biol Chem. 1998;273(16):9987-93.
447. Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, et al. Annexin II
regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest. 2004;113(1):38-48.
448. Dayal S, Chauhan AK, Jensen M, Leo L, Lynch CM, Faraci FM, et al. Paradoxical absence of
a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia. Blood.
2012;119(13):3176-83.
449. Antony AC, Utley C, Van Horne KC, Kolhouse JF. Isolation and characterization of a folate
receptor from human placenta. J Biol Chem. 1981;256(18):9684-92.
450. Antony AC. Folate receptors. Annu Rev Nutr. 1996;16:501-21.
451. Xiao X, Tang YS, Mackins JY, Sun XL, Jayaram HN, Hansen DK, et al. Isolation and
characterization of a folate receptor mRNA-binding trans-factor from human placenta.
Evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1. J Biol Chem.
2001;276(44):41510-7.
452. Sun XL, Antony AC. Evidence that a specific interaction between an 18-base cis-element in
the 5 0 -untranslated region of human folate receptor-alpha mRNA and a 46-kDa cytosolic
trans-factor is critical for translation. J Biol Chem. 1996;271(41):25539-47.
453. Tang YS, Khan RA, Zhang Y, Xiao S, Wang M, Hansen DK, et al. Incrimination of
heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) as a candidate sensor of physiolog-
ical folate deficiency. J Biol Chem. 2011;286(45):39100-15.
454. Xiao S, Tang YS, Khan RA, Zhang Y, Kusumanchi P, Stabler SP, et al. Influence of
physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human
keratinocytes in vitro and in vivo. J Biol Chem. 2012;287(15):12559-77.
455. Maret W. Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange.
Proc Natl Acad Sci USA. 1994;91(1):237-41.